Decentralized Clinical Trials

You need a modern DCT platform - powerful, flexible, innovative

Decentralized Clinical Trials

Our industry is now, more than ever, ready to move to decentralized trials (DCT) and design hybrid protocols that support trial continuity and have a more patient-centric approach.

Through discussions with our clients, it’s clear that most sponsors have struggled to implement DCT and need an innovative, modern technology platform that enables more efficient and future-ready trial processes.

The unique architecture of encapsia brings the technology to the data and provides an agile, revolutionary way to support decentralized clinical trials, allowing:

  • You to conduct a trial visit at a patient’s home, avoiding the need for patients to travel to site
  • Easy to use eSource: encapsia Direct Data Capture (DDC) is an easy to use iOS app that can be accessed from anywhere in the world. Data is saved in real-time in the cloud and can be captured even when offline
  • Smooth patient interaction: Sites can request drug dispensation, perform drug accountability, or randomize directly from the encapsia. As IRT data is automatically pushed to the platform in real time, patient contact time is smooth and quick. We also offer “hyper-integration” that adds even more speed to data delivery, reconciliation, and aggregation
  • Less monitoring: With DDC there is no transcription of the clinical data, so no need for source data verification (SDV), reducing site visits by trial monitors
  • Instant data quality: Complex validation and edit checks run immediately on data entry to ensure clean data from the start
  • Adaptability and easy adoption: encapsia supports both EDC and eSource DDC within the same study, allowing clinical teams the flexibility to manage site preferences or capabilities as needed
  • Industry leading visualizations of all your clinical data and metadata that support real-time data monitoring and oversight of study progress, enabling all stakeholders to make faster decisions and gain insights from key data views like patient profiles
Decentralized Clinical Trials
Decentralized Clinical Trials
  • Third party data, for example laboratories, ePRO, or wearables, can be uploaded by the user leveraging automated transfer rules with minimal intervention or take advantage of APIs for rapid data ingest and integration
  • All round database availability: encapsia is available 24 x 7 for the entire study team with no end user downtime for mid-study design changes or maintenance
  • Straightforward integration with other systems to support simplified site workflows e.g. eCOA, ePRO, patient randomization or legacy EDC

As the industry accelerates the adoption of new technologies, now is the time you need a modern DCT platform: powerful, flexible and innovative. Take control of your clinical data and remove the barriers to trial continuity.

Step Forward with encapsia and let us demonstrate how choosing the right technology can transform your trials of tomorrow.

Latest articles

Digital transformation can happen for any sponsor: How small and mid-sized biopharmaceutical companies can easily achieve digital innovation for their clinical data

In just a couple of decades, information technology has undergone a radical transformation –a sweeping evolution from floppy drives to data warehouses to data lakes. Our industry has unfortunately not ridden the arc of technology at the pace of other…

Read article

A better way to drive your digital transformation

As the ways in which clinical trials are conducted and monitored continue to modernize at pace, there is an urgent need for digital transformation in the industry. If sponsors are to realize their goals of running flexible, decentralized trials (DCT),…

Read article

Five predictions for the future of decentralized clinical trials

The message was clear from industry leaders last year – today’s clinical trials need decentralized solutions. More complexity means intensive data capture and continuous flows are essential, and vital strategic decisions rely on real-time data analysis and intelligence. Existing point…

Read article